TEC2022-012
DEVELOPMENT AND EVALUATION OF NANOMEDICINES
Healthcare technology, precision medicine and aging area
Objectives and lines of research
– Develop new nanosystems for drug encapsulation and study their interaction with the biological environment to optimize their therapeutic application.
– Development of nanotechnology-based strategies targeting the intestinal barrier.
– Characterization of the interaction of nanomedicines with biological barriers.
– Development of new nanomedicines for the treatment of ulcerative colitis
– Development of nanotechnology-based strategies targeting the intestinal barrier.
– Characterization of the interaction of nanomedicines with biological barriers.
– Development of new nanomedicines for the treatment of ulcerative colitis
Research team
- MARIA VICTORIA LOZANO LOPEZ
- MARIA FRANCISCA GALINDO ANAYA
- MANUEL JESÚS SANTANDER ORTEGA
- JOAQUÍN GONZÁLEZ FUENTES
IP
MARIA VICTORIA LOZANO LOPEZ
FINCA DE LA PERALEDA, S/N. 45071. Toledo
Developed by Nexora
